HQIP 8 October 2020
- This short report examines geographical variation in the management of high-risk or locally advanced prostate cancer in England, explores determinants for receipt of treatment, establishes between-hospital variation and investigates possible reasons for this variation.
- The latest figures from the National Prostate Cancer Audit (NPCA) show that in 2017-18 over 47,000 men were diagnosed with prostate cancer in England and that 41% had high risk or locally advanced disease. Approximately one third of men with high-risk or locally advanced prostate cancer do not receive radical surgery or radiotherapy treatment in England and Wales. Many factors are implicated in this potential ‘under-treatment’ but little is known about the between-hospital variation.
